Alkem Laboratories’ wholly-owned medical devices subsidiary -- Alkem MedTech has executed binding offer for acquiring a majority stake in Occlutech Holding AG (Occlutech), a global medical devices company, headquartered in Switzerland, specialising in minimally invasive cardiac implants.
Alkem MedTech intends to buy up to 55% stake in Occlutech for a consideration of 99.4 million euro (around Rs 1,074 crore), subject to statutory approvals. This acquisition represents a significant step in Alkem MedTech’s journey to build a global footprint and enables its entry into advanced cardiovascular devices.
Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.
